Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep structure in neuropathic pain patients and effect of pregabalin
2024-515820-35-02Phase 4Authorised
- Sponsor
- Helsinki University Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pregabalin in Peripheral neuropathic pain (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Pregabalin response to pain. Planned start Nov 2024; status: authorised.
02
Drugs
pregabalin
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on 2024-515820-35-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515820-35-02.